Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma

In conclusion, our data show a distinct Siglec expression profile for M- and PMN-MDSCs and propose possible sialic acid –Siglec interactions between glioma cells and MDSCs in the tumor microenvironment.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research